0001140361-25-001663.txt : 20250122 0001140361-25-001663.hdr.sgml : 20250122 20250122210404 ACCESSION NUMBER: 0001140361-25-001663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250120 FILED AS OF DATE: 20250122 DATE AS OF CHANGE: 20250122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Rakhi CENTRAL INDEX KEY: 0001856296 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 25547410 MAIL ADDRESS: STREET 1: C/O NEUROPACE INC STREET 2: 455 N BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4.xml FORM 4 X0508 4 2025-01-20 0001635088 Roivant Sciences Ltd. ROIV 0001856296 Kumar Rakhi C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true Chief Accounting Officer false Common Shares 2025-01-20 4 F 0 1057 11.15 D 203264 D Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar 2025-01-22